- Alcon Laboratories Inc
SummaryNovartis AG (Novartis) proposes to acquire a majority interest in Alcon Laboratories Inc (Alcon). Both Novartis and Alcon have global operations in the research and development, manufacturing and marketing of human health care products. In Australia, Novartis and Alcon's businesses overlap in the vision care sector.
Market definitionPlease see the attached Public Competition Assessment.
Competition analysisPlease see the attached Public Competition Assessment.
|08/04/2010||ACCC commenced review under the Merger Review Process Guidelines.|
|29/04/2010||Closing date for submissions from interested parties.|
|25/05/2010||In order to allow the ACCC to conduct further inquiries, ACCC timeline suspended. Former proposed date for announcement of ACCC's findings of 27 May 2010 deferred.|
|16/07/2010||Divestiture proposal proffered by Novartis. ACCC commenced market inquiries on divestiture proposal. ACCC timeline recommenced.|
|29/07/2010||ACCC announced it would not oppose the proposed acquisition, subject to court enforceable undertaking offered by Novartis.|
|29/07/2010||87B undertaking accepted by ACCC.|